Venture capital (VC) investment sentiment appears to be changing in the South Korean healthcare sector. The shift became more apparent towards the end of the first quarter, amid keen interest in AI-based medical solutions and medical device firms, raising hopes of a financing recovery in the broader biopharma sector.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Scrip for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?